Global Autoimmune Disease Diagnostics Market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. The Autoimmune diseases refer to body’s abnormal immune response resulting in the production of antibodies that impact or attack own cells & tissues which leads to destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases such as systematic lupus erythematosus and rheumatoid arthritis prevalent in the global scenario. The Autoimmune disease diagnostics market is primarily driven owing to a high prevalence of autoimmune diseases, escalating awareness, about autoimmune diseases, rise in the number of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key factor in the development and growth of autoimmune disease diagnostics market. For instance: according to the American Autoimmune Related Diseases Association (AARDA), the autoimmune disease impacts around 50 million individuals residing in both urban and semi-urban provinces among which 75% are females in the United States resulting in fueling the demand and adoption of autoimmune disease diagnostics market. However, high capital requirements impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Autoimmune Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high incidence & prevalence of autoimmune diseases and growth in number of research activities on autoimmune diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising aging population along with use of biosensors for autoimmune disease diagnosis would create lucrative growth prospects for the Autoimmune Disease Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories, Inc.
Grifols
Trinity Biotech
Werfen
HYCOR Biomedical
Exagen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Localized Autoimmune Disease Diagnostic
Systemic Autoimmune Disease Diagnostic
By Product:
Drugs
Therapeutic & Monitoring Equipment
Diagnostic Equipment
By Technology:
Bridge Therapy
Disease-Modifying Antirheumatic Drugs (DMARD)
Topical Therapy
Phototherapy
Helminthic Therapy
Recombinant Technology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Autoimmune Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors